Monday, November 28, 2016 8:13:47 AM
IDRA - 1.83 Pre-market now at 2.06/2.07.
Idera Pharmaceuticals, Vivelix Pharmaceuticals, Ltd. Enter Into Exclusive License Agreement for the Worldwide Rights to IMO-9200; Idera To Receive Upfront Fee Of $15M And Eligible For Future Payments Up To $140M
Idera Pharmaceuticals, Vivelix Pharmaceuticals, Ltd. Enter Into Exclusive License Agreement for the Worldwide Rights to IMO-9200; Idera To Receive Upfront Fee Of $15M And Eligible For Future Payments Up To $140M
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
